secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xencor Inc (XNCR)
CIK:        0001326732
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001326732-26-000042
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xencor reports Q1 net loss $128.9M ($1.71/shr); revenue down to $4.5M from $32.7M
--------------------------------------------------------------------------------

- Q1 2026 revenue $4.5M (vs $32.7M Q1 2025), including a $6.6M one-time reduction from Alexion royalty dispute.
- Net loss $128.9M ($1.71 diluted), vs $48.4M ($0.66) in prior year; other expense $50.8M on unrealized equity losses.
- Cash $541.8M at March end; guidance for year-end cash $380-400M, runway into mid-2028.
- XmAb819 ccRCC expansion data to be presented 2H26; XmAb541 dose data also 2H26; XmAb412 FIH starts 3Q26.
- XENITH-UC Phase 2b (XmAb942) blinded interim analysis around year-end 2026; primary endpoint 2H27.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326732/000132673226000042/0001326732-26-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326732/000132673226000042/xncr-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001326732-26-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer